Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2025 Jan 9:15:1523071.
doi: 10.3389/fgene.2024.1523071. eCollection 2024.

Editorial: Pharmacogenetics of psychiatric disorders

Sarah Allegra  1 , Silvia De Francia  1 , Stefano Comità  1 , Maria Grazia Morgese  2 , Thomas M Polasek  3
Affiliations
Editorial

Editorial: Pharmacogenetics of psychiatric disorders

Sarah Allegra et al. Front Genet. .
No abstract available

Keywords: antidepresants; cocaine; drug abuse; major depressive disorder; personalized and precision medicine; pharmacogenomic; pharmacogenomic (PGx) research; prescribing.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.

Comment on

  • Editorial on the Research Topic Pharmacogenetics of psychiatric disorders

References

    1. Biso L., Aringhieri S., Carli M., Scarselli M., Longoni B. (2024). Therapeutic drug monitoring in psychiatry: enhancing treatment precision and patient outcomes. Pharm. (Basel). May 16, 17. 10.3390/ph17050642 - DOI - PMC - PubMed
    1. Brown L. C., Stanton J. D., Bharthi K., Maruf A. A., Müller D. J., Bousman C. A. (2022). Pharmacogenomic testing and depressive symptom remission: a systematic review and meta-analysis of prospective, controlled clinical trials. Clin. Pharmacol. Ther. 112, 1303–1317. 10.1002/cpt.2748 - DOI - PMC - PubMed
    1. Lohoff F. W., Ferraro T. N. (2010). Pharmacogenetic considerations in the treatment of psychiatric disorders. Expert Opin. Pharmacother. 11, 423–439. 10.1517/14656560903508762 - DOI - PubMed
    1. Maj M., Stein D. J., Parker G., Zimmerman M., Fava G. A., De Hert M., et al. (2020). “The clinical characterization of the adult patient with depression aimed at personalization of management.” World Psychiatry 19, 269–293. 10.1002/wps.20771 - DOI - PMC - PubMed
    1. Maj M., van Os J., De Hert M., Gaebel W., Galderisi S., Green M. F., et al. (2021). “The clinical characterization of the patient with primary psychosis aimed at personalization of management.” World Psychiatry 20, 4–33. 10.1002/wps.20809 - DOI - PMC - PubMed

Publication types

LinkOut - more resources